Successful Medical Treatment With Danazol After Failed Embolization of Uterine Arteriovenous Malformation

In: Obstetrics & Gynecology · 2003 · vol. 102(4) , pp. 843–844 · doi:10.1097/00006250-200310000-00028 · W4248060851
article OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-07

Danazol successfully resolved a uterine arteriovenous malformation after failed embolization, demonstrating potential for medical management in hemodynamically stable patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In Brief BACKGROUND Transcatheter arterial embolization has been the therapy of choice for uterine arteriovenous malformations, whereas medical therapy has not been popular because of patient propensity to bleed. CASE A 29-year-old woman, gravida 3, para 0, was diagnosed with uterine arteriovenous malformation. Because initial treatment with uterine artery embolization was unsuccessful, she was ultimately treated with danazol. Resolution of the lesion after 2 weeks of danazol therapy was observed. As of follow-up at 16 months, she has remained free from further abnormal bleeding episodes and recurrence of the lesion. CONCLUSION Danazol has the potential for medical management of uterine arteriovenous malformations in hemodynamically stable patients who do not respond to embolization. Danazol has the potential for medical management of uterine arteriovenous malformation in hemodynamically stable patients who do not respond to embolization.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (3)

References (6)

Cited by (3)

Source provenance

openalex
last seen: 2026-05-10T11:12:06.935724+00:00
License: CC0 · commercial use OK